-
1
-
-
0000362047
-
Effects of calcium antagonists on the risks of coronary heart disease, cancer and bleeding
-
Ad Hoc Subcommittee of the Liaison Committee of the World Health Organisation the International Society of Hypertension Effects of calcium antagonists on the risks of coronary heart disease, cancer and bleeding. J. Hypertens. 15:1997;105-115.
-
(1997)
J. Hypertens.
, vol.15
, pp. 105-115
-
-
-
2
-
-
0029132121
-
Nifedipine. Dose-related increase in mortality in patients with coronary heart disease
-
Furberg C.D., Psaty B.M., Meyer J.V. Nifedipine. Dose-related increase in mortality in patients with coronary heart disease. Circulation. 92:1995;1326-1331.
-
(1995)
Circulation
, vol.92
, pp. 1326-1331
-
-
Furberg, C.D.1
Psaty, B.M.2
Meyer, J.V.3
-
3
-
-
0029873619
-
Risk of gastrointestinal haemorrhage with calcium antagonists in hypertensive persons over 67 years old
-
Pahor M., Guralnik J.M., Furberg C.D., Carbonin P., Havlik R. Risk of gastrointestinal haemorrhage with calcium antagonists in hypertensive persons over 67 years old. Lancet. 347:1996;1061-1065.
-
(1996)
Lancet
, vol.347
, pp. 1061-1065
-
-
Pahor, M.1
Guralnik, J.M.2
Furberg, C.D.3
Carbonin, P.4
Havlik, R.5
-
4
-
-
0030600342
-
Calcium-channel blockade and incidence of cancer in aged populations
-
Pahor M., Guralnik J.M., Ferrucci L.et al. Calcium-channel blockade and incidence of cancer in aged populations. Lancet. 348:1996;493-497.
-
(1996)
Lancet
, vol.348
, pp. 493-497
-
-
Pahor, M.1
Guralnik, J.M.2
Ferrucci, L.3
-
5
-
-
0030199181
-
Do calcium channel blockers increase the risk of cancer?
-
Pahor M., Guralnik J.M., Salive M.E., Corti M.C., Carbonin P., Havlik R.J. Do calcium channel blockers increase the risk of cancer? Am. J. Hypertens. 9:1996;695-699.
-
(1996)
Am. J. Hypertens.
, vol.9
, pp. 695-699
-
-
Pahor, M.1
Guralnik, J.M.2
Salive, M.E.3
Corti, M.C.4
Carbonin, P.5
Havlik, R.J.6
-
6
-
-
0030826328
-
Use of calcium channel blockers and breast carcinoma risk in postmenopausal women
-
Fitzpatrick A.L., Daling J.R., Furberg C.D., Kronmal R.A., Weissfeld J.L. Use of calcium channel blockers and breast carcinoma risk in postmenopausal women. Cancer. 80:1997;1438-1447.
-
(1997)
Cancer
, vol.80
, pp. 1438-1447
-
-
Fitzpatrick, A.L.1
Daling, J.R.2
Furberg, C.D.3
Kronmal, R.A.4
Weissfeld, J.L.5
-
7
-
-
0030198951
-
Calcium channel blockers and cancer: Is an association biologically plausible?
-
Daling J.R. Calcium channel blockers and cancer. is an association biologically plausible? Am. J. Hypertens. 9:1996;713-714.
-
(1996)
Am. J. Hypertens.
, vol.9
, pp. 713-714
-
-
Daling, J.R.1
-
8
-
-
0029971675
-
Case-control study on colon cancer regarding previous diseases and drug intake
-
Hardell L.F.M., Axelson O. Case-control study on colon cancer regarding previous diseases and drug intake. Int. J. Oncol. 8:1996;439-444.
-
(1996)
Int. J. Oncol.
, vol.8
, pp. 439-444
-
-
Hardell, L.F.M.1
Axelson, O.2
-
9
-
-
0030965135
-
Cancer risk in users of calcium channel blockers
-
Olsen J.H., Toft Sorensen H.T., Friis S.et al. Cancer risk in users of calcium channel blockers. Hypertension. 29:1997;1091-1094.
-
(1997)
Hypertension
, vol.29
, pp. 1091-1094
-
-
Olsen, J.H.1
Toft Sorensen, H.T.2
Friis, S.3
-
10
-
-
0032054681
-
Calcium channel blockers and the risk of cancer
-
Rosenberg L., Rao R.S., Palmer J.R.et al. Calcium channel blockers and the risk of cancer. JAMA. 279:1998;1000-1004.
-
(1998)
JAMA
, vol.279
, pp. 1000-1004
-
-
Rosenberg, L.1
Rao, R.S.2
Palmer, J.R.3
-
12
-
-
0031747323
-
Nifedipine and cancer mortality: Ten-year follow-up of patients after acute myocardial infarction
-
Jonas M., Goldbourt U., Boyko V., Mandelzweig L., Behar S., Reicher Reiss H. Nifedipine and cancer mortality. ten-year follow-up of patients after acute myocardial infarction Cardiovasc Drugs Ther. 1998:2607;12. 177-181.
-
(1998)
Cardiovasc Drugs Ther.
, vol.2607
, Issue.12
, pp. 177-181
-
-
Jonas, M.1
Goldbourt, U.2
Boyko, V.3
Mandelzweig, L.4
Behar, S.5
Reicher Reiss, H.6
-
13
-
-
0031050146
-
Calcium-channel blockers and risk of cancer
-
Jick H., Jick S., Derby L.E., Vasilakis C., Myers M.W., Meier C.R. Calcium-channel blockers and risk of cancer. Lancet. 349:1997;525-528.
-
(1997)
Lancet
, vol.349
, pp. 525-528
-
-
Jick, H.1
Jick, S.2
Derby, L.E.3
Vasilakis, C.4
Myers, M.W.5
Meier, C.R.6
-
14
-
-
0032212372
-
Calcium channel blockers, cancer incidence, and cancer mortality in a cohort of U.S. women: The Nurses' Health Study
-
Michels K.B., Rosner B.A., Walker A.M.et al. Calcium channel blockers, cancer incidence, and cancer mortality in a cohort of U.S. women: The Nurses' Health Study. Cancer. 83:1998;2003-2007.
-
(1998)
Cancer
, vol.83
, pp. 2003-2007
-
-
Michels, K.B.1
Rosner, B.A.2
Walker, A.M.3
-
15
-
-
0034645944
-
Angiotensin-converting enzyme inhibitors, calcium channel blockers, and breast cancer
-
Meier C.R., Derby L.E., Jick S.S., Jick H. Angiotensin-converting enzyme inhibitors, calcium channel blockers, and breast cancer. Arch. Intern. Med. 160:2000;349-353.
-
(2000)
Arch. Intern. Med.
, vol.160
, pp. 349-353
-
-
Meier, C.R.1
Derby, L.E.2
Jick, S.S.3
Jick, H.4
-
18
-
-
0029082271
-
Benzodiazepines and the risk of falling leading to femur fractures. Dosage more important than elimination half-life
-
Herings R.M., Stricker B.H., de Boer A., Bakker A., Sturmans F. Benzodiazepines and the risk of falling leading to femur fractures. Dosage more important than elimination half-life. Arch. Intern. Med. 155:1995;1801-1807.
-
(1995)
Arch. Intern. Med.
, vol.155
, pp. 1801-1807
-
-
Herings, R.M.1
Stricker, B.H.2
De Boer, A.3
Bakker, A.4
Sturmans, F.5
-
20
-
-
7344243229
-
Risk of esophageal and gastric adenocarcinomas in relation to use of calcium channel blockers, asthma drugs, and other medications that promote gastroesophageal reflux
-
Vaughan T.L., Farrow D.C., Hansten P.D.et al. Risk of esophageal and gastric adenocarcinomas in relation to use of calcium channel blockers, asthma drugs, and other medications that promote gastroesophageal reflux. Cancer Epidemiol. Biomarkers Prev. 7:1998;749-756.
-
(1998)
Cancer Epidemiol. Biomarkers Prev.
, vol.7
, pp. 749-756
-
-
Vaughan, T.L.1
Farrow, D.C.2
Hansten, P.D.3
-
21
-
-
0033970265
-
Calcium channel blockers and cancer
-
Cohen H.J., Pieper C.F., Hanlon J.T., Wall W.E., Burchett B.M., Havlik R.J. Calcium channel blockers and cancer. Am. J. Med. 108:2000;210-215.
-
(2000)
Am. J. Med.
, vol.108
, pp. 210-215
-
-
Cohen, H.J.1
Pieper, C.F.2
Hanlon, J.T.3
Wall, W.E.4
Burchett, B.M.5
Havlik, R.J.6
-
22
-
-
0031877888
-
Treatment with calcium antagonists does not increase the risk of fatal or non-fatal cancer in an elderly mid-European population: Results from STEPHY II. Starnberg Study on Epidemiology of Parkinsonism and Hypertension in the Elderly
-
Trenkwalder P., Hendricks P., Hense H.W. Treatment with calcium antagonists does not increase the risk of fatal or non-fatal cancer in an elderly mid-European population. results from STEPHY II. Starnberg Study on Epidemiology of Parkinsonism and Hypertension in the Elderly J. Hypertens. 16:1998;1113-1116.
-
(1998)
J. Hypertens.
, vol.16
, pp. 1113-1116
-
-
Trenkwalder, P.1
Hendricks, P.2
Hense, H.W.3
-
23
-
-
0032521470
-
Calcium channel blocking agents and risk of cancer in patients with coronary heart disease. Benzafibrate Infarction Prevention (BIP) Study Research Group
-
Braun S., Boyko V., Behar S.et al. Calcium channel blocking agents and risk of cancer in patients with coronary heart disease. Benzafibrate Infarction Prevention (BIP) Study Research Group. J. Am. Coll. Cardiol. 31:1998;804-808.
-
(1998)
J. Am. Coll. Cardiol.
, vol.31
, pp. 804-808
-
-
Braun, S.1
Boyko, V.2
Behar, S.3
-
24
-
-
0031915212
-
Cancer risk of hypertensive patients taking calcium antagonists
-
Hole D.J., Gillis C.R., McCallum I.R.et al. Cancer risk of hypertensive patients taking calcium antagonists. J. Hypertens. 16:1998;119-124.
-
(1998)
J. Hypertens.
, vol.16
, pp. 119-124
-
-
Hole, D.J.1
Gillis, C.R.2
McCallum, I.R.3
-
25
-
-
0033135919
-
Verapamil and risk of cancer in patients with coronary artery disease. DAVIT Study Group. Danish Verapamil Infarction Trial
-
(A9)
-
Sajadieh A., Storm H.H., Hansen J.F. Verapamil and risk of cancer in patients with coronary artery disease. DAVIT Study Group. Danish Verapamil Infarction Trial. Am. J. Cardiol. 83:1999;1419-1422. (A9).
-
(1999)
Am. J. Cardiol.
, vol.83
, pp. 1419-1422
-
-
Sajadieh, A.1
Storm, H.H.2
Hansen, J.F.3
-
26
-
-
0028059964
-
Mechanisms of apoptosis: Integration of genetic, biochemical, and cellular indicators
-
Stewart B.W. Mechanisms of apoptosis. integration of genetic, biochemical, and cellular indicators J. Natl. Cancer Inst. 86:1994;1286-1296.
-
(1994)
J. Natl. Cancer Inst.
, vol.86
, pp. 1286-1296
-
-
Stewart, B.W.1
-
27
-
-
0026494066
-
Calcium signals and cancer
-
Whitfield J.F. Calcium signals and cancer. Crit. Rev. Oncog. 3:1992;55-90.
-
(1992)
Crit. Rev. Oncog.
, vol.3
, pp. 55-90
-
-
Whitfield, J.F.1
-
28
-
-
0028946358
-
Calcium-mediated cell injury and cell death
-
Trump B.F., Berezesky I.K. Calcium-mediated cell injury and cell death. Faseb. J. 9:1995;219-228.
-
(1995)
Faseb. J.
, vol.9
, pp. 219-228
-
-
Trump, B.F.1
Berezesky, I.K.2
-
30
-
-
0025007511
-
Pharmacology of drugs that alter multidrug resistance in cancer
-
Ford J.M., Hait W.N. Pharmacology of drugs that alter multidrug resistance in cancer. Pharmacol. Rev. 42:1990;155-199.
-
(1990)
Pharmacol. Rev.
, vol.42
, pp. 155-199
-
-
Ford, J.M.1
Hait, W.N.2
-
31
-
-
0029939665
-
Experimental reversal of P-glycoprotein-mediated multidrug resistance by pharmacological chemosensitisers
-
Ford J.M. Experimental reversal of P-glycoprotein-mediated multidrug resistance by pharmacological chemosensitisers. Eur. J. Cancer. 32A:1996;991-1001.
-
(1996)
Eur. J. Cancer
, vol.32 A
, pp. 991-1001
-
-
Ford, J.M.1
|